This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moeller, L. C. Articles by Refetoff, S. Search for Related Content PubMed PubMed Citation Articles by Moeller, L. C. Articles by Refetoff, S.

Hypothyroidism in Thyroid Transcription Factor 1 Haploinsufficiency Is Caused by Reduced Expression of the Thyroid-Stimulating Hormone Receptor

Departments of Medicine (L.C.M., X.-H.L., S.R.), Pediatrics (S.R.), and Committee on Genetics (S.R.), The University of Chicago, Chicago, Illinois 60637; Laboratory of Metabolism (S.K., T.K.), National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; and Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (J.V.S.), University of Brussels, School of Medicine, Erasmus Hospital, B 1070 Brussels, Belgium

Address all correspondence and requests for reprints to: Samuel Refetoff, The University of Chicago, MC3090, 5841 South Maryland Avenue, Chicago, Illinois 60637. E-mail: refetoff{at}uchicago.edu.

Humans expressing one allele of the thyroid transcription factor 1 (TTF1) gene have neurological symptoms and increased serum TSH with variable degrees of hypothyroidism. Ttf1^+/- mice have also poor coordination and increased serum TSH concentration (205 ± 22 vs. 92 ± 12 mU/liter; P < 0.001) and slightly lower T₄ (46 ± 3 vs. 63 ± 6 nmol/liter; P < 0.02) as compared with Ttf1^+/+ mice. To determine whether the hypothyroidism is of central or primary origin, we examined the bioactivity of TSH, thyroidal response to exogenous TSH and the expression of genes regulated by TTF1. TSH bioactivity was normal, but T₄ response to a low but not high dose of TSH was significantly reduced in the Ttf1^+/- mice (5.5 ± 2.2 vs. 15.3 ± 4.1 nmol/liter; P < 0.03), indicating a reduced thyroidal response. Thyroid mRNAs were measured by real-time PCR (Ttf1^+/+ littermates = 100%). Ttf1^+/- mice had half the levels of TTF1 mRNA (54 ± 9; P < 0.01) and protein, confirming their haploinsufficiency. Significantly lower levels of mRNAs were observed for two of the three genes with TTF1 cis elements: TSH receptor (TSHr, 57 ± 4%; P < 0.002), thyroglobulin (63 ± 7%; P < 0.005), but not thyroid peroxidase (81 ± 12%; P > 0.05). No significant difference between the two genotypes was found for Pax8, sodium iodide symporter, and iodothyronine deiodinase 1. These results show that Ttf1 haploinsufficiency causes a reduction in the expression of TSHr and thyroglobulin, genes with TTF1 binding sites in their promoter regions. The low TSHr is only partially compensated by an increase in TSH secretion because T₄ remains mildly reduced. However, administration of a larger amount of TSH obliterates the response differences by saturating a reduced amount of receptor.

This article has been cited by other articles:

				A. Carre, G. Szinnai, M. Castanet, S. Sura-Trueba, E. Tron, I. Broutin-L'Hermite, P. Barat, C. Goizet, D. Lacombe, M.-L. Moutard, et al. Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case Hum. Mol. Genet., June 15, 2009; 18(12): 2266 - 2276. [Abstract] [Full Text] [PDF]

				E. Maquet, S. Costagliola, J. Parma, C. Christophe-Hobertus, L. L. Oligny, J.-C. Fournet, Y. Robitaille, J.-M. Vuissoz, A. Payot, S. Laberge, et al. Lethal Respiratory Failure and Mild Primary Hypothyroidism in a Term Girl with a de Novo Heterozygous Mutation in the TITF1/NKX2.1 Gene J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 197 - 203. [Abstract] [Full Text] [PDF]

				A. Burniat, L. Jin, V. Detours, N. Driessens, J.-C. Goffard, M. Santoro, J. Rothstein, J. E. Dumont, F. Miot, and B. Corvilain Gene Expression in RET/PTC3 and E7 Transgenic Mouse Thyroids: RET/PTC3 But Not E7 Tumors Are Partial and Transient Models of Human Papillary Thyroid Cancers Endocrinology, October 1, 2008; 149(10): 5107 - 5117. [Abstract] [Full Text] [PDF]

				L. C. Moeller, M. Alonso, X. Liao, V. Broach, A. Dumitrescu, J. Van Sande, L. Montanelli, S. Skjei, C. Goodwin, H. Grasberger, et al. Pituitary-Thyroid Setpoint and Thyrotropin Receptor Expression in Consomic Rats Endocrinology, October 1, 2007; 148(10): 4727 - 4733. [Abstract] [Full Text] [PDF]

				M. Milenkovic, X. De Deken, L. Jin, M. De Felice, R. Di Lauro, J. E Dumont, B. Corvilain, and F. Miot Duox expression and related H2O2 measurement in mouse thyroid: onset in embryonic development and regulation by TSH in adult J. Endocrinol., March 1, 2007; 192(3): 615 - 626. [Abstract] [Full Text] [PDF]

				M. A. Christoffolete, R. Arrojo e Drigo, F. Gazoni, S. M. Tente, V. Goncalves, B. S. Amorim, P. R. Larsen, A. C. Bianco, and A. M. Zavacki Mice with Impaired Extrathyroidal Thyroxine to 3,5,3'-Triiodothyronine Conversion Maintain Normal Serum 3,5,3'-Triiodothyronine Concentrations Endocrinology, March 1, 2007; 148(3): 954 - 960. [Abstract] [Full Text] [PDF]

				T. Kusakabe, A. Kawaguchi, N. Hoshi, R. Kawaguchi, S. Hoshi, and S. Kimura Thyroid-Specific Enhancer-Binding Protein/NKX2.1 Is Required for the Maintenance of Ordered Architecture and Function of the Differentiated Thyroid Mol. Endocrinol., August 1, 2006; 20(8): 1796 - 1809. [Abstract] [Full Text] [PDF]

				A. A. Nikrodhanond, T. M. Ortiga-Carvalho, N. Shibusawa, K. Hashimoto, X. H. Liao, S. Refetoff, M. Yamada, M. Mori, and F. E. Wondisford Dominant Role of Thyrotropin-releasing Hormone in the Hypothalamic-Pituitary-Thyroid Axis J. Biol. Chem., February 24, 2006; 281(8): 5000 - 5007. [Abstract] [Full Text] [PDF]

				G. Vassart and J. E. Dumont Thyroid Dysgenesis: Multigenic or Epigenetic ... or Both? Endocrinology, December 1, 2005; 146(12): 5035 - 5037. [Full Text] [PDF]

				E. Amendola, P. De Luca, P. E. Macchia, D. Terracciano, A. Rosica, G. Chiappetta, S. Kimura, A. Mansouri, A. Affuso, C. Arra, et al. A Mouse Model Demonstrates a Multigenic Origin of Congenital Hypothyroidism Endocrinology, December 1, 2005; 146(12): 5038 - 5047. [Abstract] [Full Text] [PDF]

				J. A. Knauf, X. Ma, E. P. Smith, L. Zhang, N. Mitsutake, X.-H. Liao, S. Refetoff, Y. E. Nikiforov, and J. A. Fagin Targeted Expression of BRAFV600E in Thyroid Cells of Transgenic Mice Results in Papillary Thyroid Cancers that Undergo Dedifferentiation Cancer Res., May 15, 2005; 65(10): 4238 - 4245. [Abstract] [Full Text] [PDF]

				M. Tonacchera, A. Perri, G. De Marco, P. Agretti, M. E. Banco, C. Di Cosmo, L. Grasso, P. Vitti, L. Chiovato, and A. Pinchera Low Prevalence of Thyrotropin Receptor Mutations in a Large Series of Subjects with Sporadic and Familial Nonautoimmune Subclinical Hypothyroidism J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5787 - 5793. [Abstract] [Full Text] [PDF]

				M. De Felice and R. Di Lauro Thyroid Development and Its Disorders: Genetics and Molecular Mechanisms Endocr. Rev., October 1, 2004; 25(5): 722 - 746. [Abstract] [Full Text] [PDF]